Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level

Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 447-453

  Kashihara, Takeshi ^a   Ohki, Atsushi ^a   Kobayashi, Tomoko ^a   Sato, Tomomi ^a   Nishizawa, Hitoshi ^a   Ogawa, Kohei ^a   Tako, Hajime ^a   Kawakami, Fusao ^a   Tsuji, Motomu ^a   Tamaoka, Koichi ^a  

^a Itami City Hospital   (Japan)

Author keywords

CYFRA 21 1; Cytokeratin 19; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; DECARBOXYPROTHROMBIN; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TUMOR GROWTH;

ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PROTHROMBIN; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 7144262391     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050112     Document Type: Article

References (17)

1. Honda H, Onitsuka H, Yasumori K, et al. Intrahepatic peripheral cholangiocarcinoma: Two-phase dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 1993;17:397-402.
2. Hayashi N, Matsuda Y, Asano Y, et al. An autopsy case of cholangiocellular carcinoma associated with HCV antibody-positive liver cirrhosis (in Japanese with English abstract). Kanzo (Acta Hepatol Jap) 1994;35:309-313.
3. Stieber P, Bodenmüller H, Banauch D, et al. Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer. Clin Biochem 1993;26:301-304.
4. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
5. Molina R, Agusti C, Filella X, et al. Study of a new tumor marker, CYFRA21-1, in malignant and nonmalignant diseases. Tumor Biol 1994;15:318-325.
6. Takezaki E, Murakami S, Tsuda T, et al. Serum CYFRA as a tumor marker for hepatocellular carcinoma (in Japanese with English abstract). Gan no Rinshou (Jpn J Cancer Clin) 1995;41:977-981.
7. Pujol JL, Grenier J, Daurès JP, et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53:61-66.
8. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan. Report 11 (in Japanese with English abstract). Kanzo (Acta Hepatol Jap) 1995;36:208-218.
9. Yamanaka O, Kawanami M, Ozaki H, et al. Usefulness of carbohydrate antigen 19-9 (CA19-9) for the diagnosis of cholangioma - in the role of a screening tumor marker in patients with elevated serum alkaline phosphatase, leucine aminopeptidase, and/or γ-glutamyl transpeptidase (in Japanese). Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1985;82:1419.
10. Moll R, Schiller DL, Franke WW, et al. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-580.
11. Broers JLV, Ramaekers FCS, Rot MK, et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988;48:3221-3229.
12. Sakahara H, Kousaka T, Hattori N, et al. Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1" (in Japanese with English abstract). Kaku Igaku (Jpn J Nuclear Medicine) 1993;30:1475-1479.
13. Nakata B, Chung YS, Kato Y, et al. Clinical significance of serum CYFRA21-1 in gastric cancer. Br J Cancer 1996;73:1529-1532.
14. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993;13:113-122.
15. Johnson DE, Herndier BG, Medeiros LJ, et al. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988;12:187-197.
16. Van Eyken P, Sciot R, Paterson A, et al. Cytokeratin expression in hepatocellular carcinoma: An immunohistochemical study. Hum Pathol 1988;19:562-568.
17. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular and cholangiocarcinoma: Proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995;26:956-964.